ConductScience.org, home

Trial · NCT03228680

Results by group156

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Circulating Levels of Endocrine Parameter (Progesterone) on Stimulation Day 6FE 999049 (Follitropin Delta)1.7Inter-Quartile Range 0.8 to 2.4nmol/L
Circulating Levels of Endocrine Parameter (Progesterone) on Stimulation Day 6FOLLISTIM (Follitropin Beta)1.7Inter-Quartile Range 0.8 to 2.65nmol/L
Circulating Levels of Endocrine Parameter (Progesterone) at End-of-stimulationFE 999049 (Follitropin Delta)2.5Inter-Quartile Range 1.9 to 3.5nmol/L
Circulating Levels of Endocrine Parameter (Progesterone) at End-of-stimulationFOLLISTIM (Follitropin Beta)3.1Inter-Quartile Range 2.3 to 4.3nmol/L
Circulating Levels of Endocrine Parameters (Inhibin A) on Stimulation Day 6FE 999049 (Follitropin Delta)113.1Inter-Quartile Range 75.1 to 171.9ng/L
Circulating Levels of Endocrine Parameters (Inhibin A) on Stimulation Day 6FOLLISTIM (Follitropin Beta)129.8Inter-Quartile Range 81.6 to 210.6ng/L
Circulating Levels of Endocrine Parameters (Inhibin A) at End-of-stimulationFE 999049 (Follitropin Delta)323.8Inter-Quartile Range 222.1 to 458.8ng/L
Circulating Levels of Endocrine Parameters (Inhibin A) at End-of-stimulationFOLLISTIM (Follitropin Beta)390.3Inter-Quartile Range 301.0 to 551.1ng/L
Circulating Levels of Endocrine Parameters (Inhibin B) on Stimulation Day 6FE 999049 (Follitropin Delta)570.5Inter-Quartile Range 396.0 to 853.0ng/L
Circulating Levels of Endocrine Parameters (Inhibin B) on Stimulation Day 6FOLLISTIM (Follitropin Beta)686.0Inter-Quartile Range 431.0 to 1004.0ng/L
Circulating Levels of Endocrine Parameters (Inhibin B) at End-of-stimulationFE 999049 (Follitropin Delta)686.0Inter-Quartile Range 461.0 to 1057.0ng/L
Circulating Levels of Endocrine Parameters (Inhibin B) at End-of-stimulationFOLLISTIM (Follitropin Beta)734.5Inter-Quartile Range 492.5 to 1120.5ng/L
Number of Stimulation DaysFE 999049 (Follitropin Delta)8.9Standard Deviation 1.9Days
Number of Stimulation DaysFOLLISTIM (Follitropin Beta)8.8Standard Deviation 1.7Days
Total Gonadotropin Dose of FE 999049FE 999049 (Follitropin Delta)83.5Standard Deviation 28.9μg
Total Gonadotropin Dose of FOLLISTIMFOLLISTIM (Follitropin Beta)1499Standard Deviation 514IU
Number of Participants With Adverse Events (AEs) Stratified by IntensityFE 999049 (Follitropin Delta)Any AE73Participants
Number of Participants With Adverse Events (AEs) Stratified by IntensityFOLLISTIM (Follitropin Beta)Any AE92Participants
Number of Participants With Adverse Events (AEs) Stratified by IntensityFE 999049 (Follitropin Delta)Mild AE69Participants
Number of Participants With Adverse Events (AEs) Stratified by IntensityFOLLISTIM (Follitropin Beta)Mild AE86Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03228680/results?page=5